Login
$CLYM
$9.82 -$0.12 (1.23%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Aoife Brennan, M.B., Ch.B. Also a director
President and Chief Executive Officer
50 Not stated $2,922,223
Susan Altschuller, Ph.D., MBA
Chief Financial Officer
44 Since 2025
1 year
$1,151,372
Perrin Wilson, Ph.D.
Chief Business Officer
47 Since 2025
1 year
$1,537,367

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Jul 1, 2026

Directors
7
serving now
Average tenure
2.2 years
from year joined
CEO also chairs the board
No
Douglas Williams, Ph.D.
Director Age On board Committees Other public boards 2025 pay Source
Douglas Williams, Ph.D.
67 2024
2 years
Audit Committee
Camp4 Therapeutics Corp. $205,331
Aoife Brennan, M.B., Ch.B.
50 2024
2 years
None stated Xilio Therapeutics, Inc. Paid as CEO
Alexander (Bo) Cumbo
55 2025
1 year
Audit Committee
Vor Biopharma, Inc. $168,667
Kimberlee (Kim) Drapkin
58 2025
1 year
Audit Committee · Chair Nominating and Corporate Governance Committee
LENZ Therapeutics, Inc., Imugene Limited, Acumen Pharmaceuticals, Inc $170,569
Judith Dunn, Ph.D.
63 2021
5 years
None stated None stated $89,748
Stephen Thomas, Ph.D.
37 2024
2 years
None stated None stated $79,123
Breanna O’Reilly Joined Jul 1, 2026
- - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support